1. FDA begins proceedings to remove erythromycin estolate from market;FDA Drug Bull.,1979
2. FDA begins proceedings to remove erythromycin estolate from market;Federal Register,1979
3. Erythromycin ethylsuccinate-induced cholestasis;Viteri;Gastroenterology,1979
4. Erythromycin ethylsuccinate hepatotoxicity;Sullivan;J. Amer. med. Ass.,1980